{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:50:00Z","timestamp":1777643400026,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["JAMA Facial Plast Surg"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Evidence is robust for the effectiveness of microneedle therapy in the management of postacne atrophic scarring. A home-based topical treatment with an efficacy comparable to microneedling would be a useful addition in the armamentarium of acne scar management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the efficacy of topical tazarotene gel, 0.1%, with microneedling therapy in the management of moderate to severe atrophic acne scars.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Prospective, observer-blinded, active-controlled, randomized clinical trial with 6 months of follow-up conducted between June 2, 2017, and February 28, 2018, at a tertiary care hospital in India. Thirty-six patients with grade 2 to 4 facial atrophic postacne scars and without a history of procedural treatment of acne scars within the previous year were recruited. Analyses were conducted using data from the evaluable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Both halves of each participant\u2019s face were randomized to receive either microneedling or topical tazarotene therapy. Microneedling was conducted on 1 side of the face with a dermaroller having a needle length of 1.5 mm for a total of 4 sessions during the course of 3 months. Participants were instructed to apply topical tazarotene gel, 0.1%, to the other side of the face once every night during this same period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Patients were followed up at 3 and 6 months by a blinded observer, and improvements in acne scar severity based on Goodman and Baron quantitative and qualitative scores and a subjective independent dermatologist score (range, 0-10, with higher scores indicating better improvement) were assessed. Patient satisfaction was assessed using a patient global assessment score (ranging from 0 for no response to 10 for maximum improvement) at these follow-up visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 36 participants (13 men and 23 women; mean [range] age, 23.4 [18-30] years), and the median (interquartile range [IQR]) duration of acne was 6 (4-8) years. For the 34 participants included in the complete data analyses, the median (IQR) quantitative score for acne scar severity at the 6-month follow-up visit following treatment with either tazarotene (from a baseline of 8.0 [6.0-9.8] to 5.0 [3.0-6.0]) or microneedling (from a baseline of 7.0 [6.0-10.8] to 4.5 [3.0-6.0]) indicated significant improvement (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001) that was comparable for both treatments (median [IQR] change in severity score from baseline, 2.5 [2.0-4.0] vs 3.0 [2.0-4.0];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.42). By contrast, median qualitative acne scar scores were the same for both treatment groups at baseline and did not significantly change following either treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The present clinical trial showed comparable outcomes of both treatments for the overall improvement of quantitative facial acne scar severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/jamanetwork.com\/journals\/jamafacialplasticsurgery\/pages\/instructions-for-authors\/#SecLevelofEvidence\/Ethnicity\">1<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03170596\">NCT03170596<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamafacial.2018.1404","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T17:38:49Z","timestamp":1542649129000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars"],"prefix":"10.1177","volume":"21","author":[{"given":"T. P.","family":"Afra","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Razmi T","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[{"name":"National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"issue":"8","key":"e_1_3_1_2_2","first-page":"50","article-title":"Practical evaluation and management of atrophic acne scars: tips for the general dermatologist","volume":"4","author":"Fife D","year":"2011","unstructured":"Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011; 4(8):50-57. 21909457","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"e_1_3_1_3_2","first-page":"97","article-title":"Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA","volume":"16","author":"Tan J","year":"2017","unstructured":"Tan J, , Kang S, , Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA. J Drugs Dermatol. 2017; 16(2):97-102. 28300850","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12885"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000924"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001248"},{"issue":"2","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2015.09.024","article-title":"Microneedling in skin of color: a review of uses and efficacy","volume":"74","author":"Cohen BE","year":"2016","unstructured":"Cohen BE, , Elbuluk N. Microneedling in skin of color: a review of uses and efficacy. J Am Acad Dermatol. 2016; 74(2):348-355. doi:10.1016\/j.jaad.2015.09.024, 26549251","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jocd.12095","article-title":"Microneedling for acne scars in Asian skin type: an effective low cost treatment modality","volume":"13","author":"Dogra S","year":"2014","unstructured":"Dogra S, , Yadav S, , Sarangal R. Microneedling for acne scars in Asian skin type: an effective low cost treatment modality. J Cosmet Dermatol. 2014; 13(3):180-187. doi:10.1111\/jocd.12095, 25196684","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1524-4725.2010.01854.x","article-title":"Percutaneous collagen induction versus full-concentration trichloroacetic acid in the treatment of atrophic acne scars","volume":"37","author":"Leheta T","year":"2011","unstructured":"Leheta T, , El Tawdy A, , Abdel Hay R, , Farid S. Percutaneous collagen induction versus full-concentration trichloroacetic acid in the treatment of atrophic acne scars. Dermatol Surg. 2011; 37(2):207-216. doi:10.1111\/j.1524-4725.2010.01854.x, 21269351","journal-title":"Dermatol Surg"},{"issue":"1","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jocd.12071","article-title":"A split-face comparative study to evaluate efficacy of combined subcision and dermaroller against combined subcision and cryoroller in treatment of acne scars","volume":"13","author":"Gadkari R","year":"2014","unstructured":"Gadkari R, , Nayak C. A split-face comparative study to evaluate efficacy of combined subcision and dermaroller against combined subcision and cryoroller in treatment of acne scars. J Cosmet Dermatol. 2014; 13(1):38-43. doi:10.1111\/jocd.12071, 24641604","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14764172.2013.793584","article-title":"Randomized clinical trial of CO2 laser pinpoint irradiation technique with\/without needling for ice pick acne scars","volume":"15","author":"Mohammed G","year":"2013","unstructured":"Mohammed G. Randomized clinical trial of CO2 laser pinpoint irradiation technique with\/without needling for ice pick acne scars. J Cosmet Laser Ther. 2013; 15(3):177-182. doi:10.3109\/14764172.2013.793584, 23581798","journal-title":"J Cosmet Laser Ther"},{"issue":"5","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI9362","article-title":"c-Jun\u2013dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid","volume":"106","author":"Fisher GJ","year":"2000","unstructured":"Fisher GJ, , Datta S, , Wang Z, . c-Jun\u2013dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest. 2000; 106(5):663-670. doi:10.1172\/JCI9362, 10974019","journal-title":"J Clin Invest"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14026"},{"issue":"2","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13555-018-0231-8","article-title":"Adapalene 0.3% gel shows efficacy for the treatment of atrophic acne scars","volume":"8","author":"Loss MJ","year":"2018","unstructured":"Loss MJ, , Leung S, , Chien A, , Kerrouche N, , Fischer AH, , Kang S. Adapalene 0.3% gel shows efficacy for the treatment of atrophic acne scars. Dermatol Ther (Heidelb). 2018; 8(2):245-257. doi:10.1007\/s13555-018-0231-8, 29549598","journal-title":"Dermatol Ther (Heidelb)"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"issue":"12","key":"e_1_3_1_16_2","first-page":"1458","article-title":"Postacne scarring: a qualitative global scarring grading system","volume":"32","author":"Goodman GJ","year":"2006","unstructured":"Goodman GJ, , Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006; 32(12):1458-1466. 17199653","journal-title":"Dermatol Surg"},{"issue":"1","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1473-2165.2006.00222.x","article-title":"Postacne scarring\u2014a quantitative global scarring grading system","volume":"5","author":"Goodman GJ","year":"2006","unstructured":"Goodman GJ, , Baron JA. Postacne scarring\u2014a quantitative global scarring grading system. J Cosmet Dermatol. 2006; 5(1):48-52. doi:10.1111\/j.1473-2165.2006.00222.x, 17173571","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jocd.12207","article-title":"Combined autologous platelet-rich plasma with microneedling verses microneedling with distilled water in the treatment of atrophic acne scars: a concurrent split-face study","volume":"15","author":"Asif M","year":"2016","unstructured":"Asif M, , Kanodia S, , Singh K. Combined autologous platelet-rich plasma with microneedling verses microneedling with distilled water in the treatment of atrophic acne scars: a concurrent split-face study. J Cosmet Dermatol. 2016; 15(4):434-443. doi:10.1111\/jocd.12207, 26748836","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00003495-199855050-00008","article-title":"Tazarotene","volume":"55","author":"Foster RH","year":"1998","unstructured":"Foster RH, , Brogden RN, , Benfield P. Tazarotene. Drugs. 1998; 55(5):705-711. doi:10.2165\/00003495-199855050-00008, 9585866","journal-title":"Drugs"},{"issue":"6","key":"e_1_3_1_20_2","first-page":"349","article-title":"Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study","volume":"63","author":"Shalita AR","year":"1999","unstructured":"Shalita AR, , Chalker DK, , Griffith RF, . Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis. 1999; 63(6):349-354. 10388959","journal-title":"Cutis"},{"issue":"11","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.clinthera.2004.11.012","article-title":"Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials","volume":"26","author":"Shalita AR","year":"2004","unstructured":"Shalita AR, , Berson DS, , Thiboutot DM, ; Tazarotene Cream in Acne Clinical Study Investigator Group. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin Ther. 2004; 26(11):1865-1873. doi:10.1016\/j.clinthera.2004.11.012, 15639698","journal-title":"Clin Ther"},{"issue":"1","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/14740338.2016.1117605","article-title":"Tazarotene foam, 0.1%, for the treatment of acne","volume":"15","author":"Smith JA","year":"2016","unstructured":"Smith JA, , Narahari S, , Hill D, , Feldman SR. Tazarotene foam, 0.1%, for the treatment of acne. Expert Opin Drug Saf. 2016; 15(1):99-103. doi:10.1517\/14740338.2016.1117605, 26560170","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"e_1_3_1_23_2","first-page":"4","article-title":"A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris","volume":"69","author":"Webster GF","year":"2002","unstructured":"Webster GF, , Guenther L, , Poulin YP, , Solomon BA, , Loven K, , Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002; 69(2)(suppl):4-11. 12095066","journal-title":"Cutis"},{"issue":"5","key":"e_1_3_1_24_2","first-page":"549","article-title":"Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris","volume":"9","author":"Tanghetti E","year":"2010","unstructured":"Tanghetti E, , Dhawan S, , Green L, . Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. J Drugs Dermatol. 2010; 9(5):549-558. 20480800","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.1984.tb04014.x","article-title":"Effect of vitamin A and its derivatives on collagen production and chemotactic response of fibroblasts","volume":"111","author":"Hein R","year":"1984","unstructured":"Hein R, , Mensing H, , M\u00fcller PK, , Braun-Falco O, , Krieg T. Effect of vitamin A and its derivatives on collagen production and chemotactic response of fibroblasts. Br J Dermatol. 1984; 111(1):37-44. doi:10.1111\/j.1365-2133.1984.tb04014.x, 6234916","journal-title":"Br J Dermatol"},{"issue":"8","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamadermatol.2017.2077","article-title":"Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations","volume":"153","author":"Spring LK","year":"2017","unstructured":"Spring LK, , Krakowski AC, , Alam M, . Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017; 153(8):802-809. doi:10.1001\/jamadermatol.2017.2077, 28658462","journal-title":"JAMA Dermatol"},{"key":"e_1_3_1_27_2","first-page":"57","volume-title":"Acne Scars: Classification and Treatment","author":"Fabbrocini G","year":"2009","unstructured":"Fabbrocini G, , Fardella N, , Monfrecola A. Needling. In: Tosti A, De Padova MP, , Beer K, eds. Acne Scars: Classification and Treatment. CRC Press; 2009:57-66."},{"issue":"4","key":"e_1_3_1_28_2","first-page":"438","article-title":"The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies","volume":"12","author":"Feldman SR","year":"2013","unstructured":"Feldman SR, , Werner CP, , Ali\u00f3 Saenz AB. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies. J Drugs Dermatol. 2013; 12(4):438-446. 23652892","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"e_1_3_1_29_2","first-page":"177","article-title":"Combined use of skin needling and platelet-rich plasma in acne scarring treatment","volume":"24","author":"Fabbrocini G","year":"2011","unstructured":"Fabbrocini G, , De Vita V, , Pastore F, . Combined use of skin needling and platelet-rich plasma in acne scarring treatment. Cosmet Dermatol. 2011; 24(4):177-183.","journal-title":"Cosmet Dermatol"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.8687"},{"issue":"4","key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.138.4.481","article-title":"Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel","volume":"138","author":"Bershad S","year":"2002","unstructured":"Bershad S, , Kranjac Singer G, , Parente JE, . Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002; 138(4):481-489. doi:10.1001\/archderm.138.4.481, 11939810","journal-title":"Arch Dermatol"},{"issue":"7","key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/1346-8138.12471","article-title":"Treatment of acne vulgaris with fractional radiofrequency microneedling","volume":"41","author":"Kim ST","year":"2014","unstructured":"Kim ST, , Lee KH, , Sim HJ, , Suh KS, , Jang MS. Treatment of acne vulgaris with fractional radiofrequency microneedling. J Dermatol. 2014; 41(7):586-591. doi:10.1111\/1346-8138.12471, 24807263","journal-title":"J Dermatol"},{"issue":"10","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/lsm.22200","article-title":"Assessment of treatment efficacy and sebosuppressive effect of fractional radiofrequency microneedle on acne vulgaris","volume":"45","author":"Lee KR","year":"2013","unstructured":"Lee KR, , Lee EG, , Lee HJ, , Yoon MS. Assessment of treatment efficacy and sebosuppressive effect of fractional radiofrequency microneedle on acne vulgaris. Lasers Surg Med. 2013; 45(10):639-647. doi:10.1002\/lsm.22200, 24249246","journal-title":"Lasers Surg Med"},{"issue":"1","key":"e_1_3_1_34_2","first-page":"2","article-title":"Skin cell proliferation stimulated by microneedles","volume":"4","author":"Liebl H","year":"2012","unstructured":"Liebl H, , Kloth LC. Skin cell proliferation stimulated by microneedles. J Am Coll Clin Wound Spec. 2012; 4(1):2-6. doi:10.1016\/j.jccw.2012.11.001, 24527373","journal-title":"J Am Coll Clin Wound Spec"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22607"}],"container-title":["JAMA Facial Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1001\/jamafacial.2018.1404","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1001\/jamafacial.2018.1404","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1001\/jamafacial.2018.1404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:26:04Z","timestamp":1777443964000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1001\/jamafacial.2018.1404"}},"subtitle":["A Randomized Active-Controlled Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1001\/jamafacial.2018.1404"],"URL":"https:\/\/doi.org\/10.1001\/jamafacial.2018.1404","relation":{},"ISSN":["2168-6076","2168-6092"],"issn-type":[{"value":"2168-6076","type":"print"},{"value":"2168-6092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}